Molecular Biosystems (US) MBI starts Phase II trials for Oralex:
This article was originally published in Clinica
Executive Summary
Molecular Biosystems (US) has started Phase II clinical trials for Oralex, its gastrointestinal agent for enhancing abdominal imaging (see Clinica No 657, p 18).